Exacerbation Prevention and Management of Bronchiectasis

Exacerbation Prevention and Management of Bronchiectasis

Bronchiectasis, which is characterized by irreversibly damaged and dilated bronchi, causes significant symptoms, poor quality of life, and increased economic burden and mortality rates. Despite its increasing prevalence and clinical significance, bronchiectasis was previously regarded as an orphan d...

Full description

Bibliographic Details
Main Author:	Joon Young Choi
Format:	Article
Language:	English
Published:	The Korean Academy of Tuberculosis and Respiratory Diseases 2023-07-01
Series:	Tuberculosis and Respiratory Diseases
Subjects:	bronchiectasis treatment exacerbation inhaled antibiotics macrolide airway clearance therapy physiotherapy
Online Access:	http://e-trd.org/upload/pdf/trd-2023-0010.pdf

Similar Items

Active cycle of breathing technique versus oscillating PEP therapy versus walking with huffing during an acute exacerbation of bronchiectasis: a randomised, controlled trial protocol
by: Jennifer Phillips, et al.
Published: (2023-01-01)

Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
by: Lotte C. Terpstra, et al.
Published: (2022-12-01)

Blood eosinophil percentage as a predictor of response to inhaled corticosteroid in bronchiectasis
by: Wang Chun Kwok, et al.
Published: (2023-06-01)

The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
by: L.C. Terpstra, et al.
Published: (2022-12-01)

Outpatient parenteral antibiotic therapy (OPAT) for the management of bronchiectasis
by: Jacky Tu, et al.
Published: (2023-09-01)

Systemic Inflammation during and after Bronchiectasis Exacerbations: Impact of <i>Pseudomonas aeruginosa</i>
by: Rosario Menéndez, et al.
Published: (2020-08-01)

Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study
by: So Rae Kim, et al.
Published: (2023-05-01)

High-sensitivity C-reactive protein level in stable-state bronchiectasis predicts exacerbation risk
by: Wang Chun Kwok, et al.
Published: (2024-02-01)

Differential airway resistome and its correlations with clinical characteristics in Haemophilus- or Pseudomonas-predominant microbial subtypes of bronchiectasis
by: Xin-zhu Yi, et al.
Published: (2023-11-01)

Clinical outcomes of long-term inhaled combination therapies in patients with bronchiectasis and airflow obstruction
by: Hyo Jin Lee, et al.
Published: (2024-01-01)

Non-Cystic Fibrosis Bronchiectasis in Pediatric Age: A Case Series in a Metropolitan Area of Northern Italy
by: Marcella Gallucci, et al.
Published: (2022-09-01)

A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age
by: Marcella Gallucci, et al.
Published: (2017-12-01)

The Short Term Influence of Chest Physiotherapy on Lung Function Parameters in Children With Cystic Fibrosis and Primary Ciliary Dyskinesia
by: Bjarne Vandervoort, et al.
Published: (2022-05-01)

Exacerbations and Changes in Physical Activity and Sedentary Behaviour in Patients with Bronchiectasis after 1 Year
by: Victoria Alcaraz-Serrano, et al.
Published: (2021-03-01)

Assessment of Bronchiectasis Severity: The FACED Score versus The Bronchiectasis Severity Index (BSI)
by: Dr. Jitendrakumar A. Sisodia, et al.
Published: (2023-12-01)

Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis
by: Hung-Yu Huang, et al.
Published: (2023-02-01)

Prognostic factors of pulmonary exacerbations severity in pediatric bronchiectasis: a retrospective cohort study
by: Heba A. Ali, et al.
Published: (2023-07-01)

Comparison between active cycles of breathing with postural drainage versus conventional chest physiotherapy in subjects with bronchiectasis
by: Hesham A. AbdelHalim, et al.
Published: (2016-01-01)

The efficacy of azithromycin to prevent exacerbation of non-cystic fibrosis bronchiectasis: a meta-analysis of randomized controlled studies
by: Kui Li, et al.
Published: (2022-10-01)

Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity
by: Miguel Ángel Martinez-García, et al.
Published: (2022-09-01)

In bronchiectasis, poor physical capacity correlates with poor quality of life
by: Jarkko Mäntylä, et al.
Published: (2022-12-01)

Altered community compositions of Proteobacteria in adults with bronchiectasis
by: Guan WJ, et al.
Published: (2018-07-01)

Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review
by: Riccardo Inchingolo, et al.
Published: (2021-03-01)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
by: Grace Oscullo, et al.
Published: (2023-10-01)

Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial
by: Lotte C. Terpstra, et al.
Published: (2023-08-01)

Management of Bronchiectasis in Adults
by: Mariana Conceição, et al.
Published: (2022-01-01)

Efficacy of pulmonary rehabilitation plus chest physiotherapy versus chest physiotherapy alone in patients with bronchiectasis
by: Asmaa M Abdo, et al.
Published: (2024-01-01)

Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study
by: Miguel Ángel Martínez-García, et al.
Published: (2020-07-01)

Sputum pathogen spectrum and clinical outcomes of upper respiratory tract infection in bronchiectasis exacerbation: a prospective cohort study
by: Yan Huang, et al.
Published: (2023-12-01)

Bronchiectasis-associated infections and outcomes in a large, geographically diverse electronic health record cohort in the United States
by: Samantha G Dean, et al.
Published: (2024-04-01)

Surgical Treatment of Congenital Bronchiectasis in Childhood
by: Kh.X. Sultanov, et al.
Published: (2022-12-01)

Safety and Efficacy of Devices Delivering Inhaled Antibiotics among Adults with Non-Cystic Fibrosis Bronchiectasis: A Systematic Review and a Network Meta-Analysis
by: Sofia Tejada, et al.
Published: (2022-02-01)

The Perceptions of Telehealth Physiotherapy for People with Bronchiectasis during a Global Pandemic—A Qualitative Study
by: Annemarie L. Lee, et al.
Published: (2022-02-01)

Bronchiectasis: new therapies and new perspectives
by: Chalmers, James D, et al.
Published: (2018)

Bronchiectasis in COPD patients: more than a comorbidity?
by: Martinez-Garcia MA, et al.
Published: (2017-05-01)

Asthma-Like Features and Anti-Asthmatic Drug Prescription in Children with Non-CF Bronchiectasis
by: Konstantinos Douros, et al.
Published: (2020-12-01)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
by: Sun Hye Shin, et al.
Published: (2022-05-01)

Bronchiectasis and Other Chronic Airway Diseases: A Clinical-based Approach
by: Letizia Traversi, et al.
Published: (2022-01-01)

Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report
by: Pietro Impellizzeri, et al.
Published: (2022-08-01)

Physiotherapy management of first nations children with bronchiectasis from remote top end communities of the northern territory: a retrospective chart audit
by: A Welford, et al.
Published: (2023-10-01)